OF
Ostronic Francis Patrick Director
Board M
US US · SEC (Form 4)
€210,179
▲ Purchases (23 ops.)
Browse the detailed record of transactions filed by Ostronic Francis Patrick, Director. Director active across 1 companies, notably Cyclo Therapeutics, Inc.. In total, 29 reports have been recorded. Total volume traded: €210k. The latest transaction was filed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations 29 total
€23 12 shares @ €1.8905 0.0% of flow
Common Stock
SEC:0001437749-22-013286:0 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) 05,249 shares 0
Common Stock
SEC:0001437749-22-010958:0 · 3 May 2022
€13,305 5,000 shares @ €2.661 5.3% of flow
Common Stock
SEC:0001437749-22-008454:0 · 6 Apr 2022
€14,428 5,000 shares @ €2.8857 12.1% of flow
Common Stock
SEC:0001437749-22-002467 · 4 Feb 2022
€14,428 5,000 shares @ €2.8857 5.7% of flow
Common Stock
SEC:0001437749-22-002467:0 · 4 Feb 2022
05,065 shares 0
Common Stock
SEC:0001437749-22-002055:0 · 28 Jan 2022
05,065 shares 0
Common Stock
SEC:0001437749-22-002055 · 28 Jan 2022
€6,613 2,000 shares @ €3.3064 5.5% of flow
Common Stock
SEC:0001437749-22-001472 · 24 Jan 2022
Ideal exit: 21 Oct 2022 (T+270) €6,613 2,000 shares @ €3.3064 2.6% of flow
Common Stock
SEC:0001437749-22-001472:0 · 24 Jan 2022
Ideal exit: 21 Oct 2022 (T+270) €3,997 1,132 shares @ €3.5306 3.3% of flow
Common Stock
SEC:0001437749-22-001184 · 19 Jan 2022
Ideal exit: 16 Oct 2022 (T+270) €3,997 1,132 shares @ €3.5306 1.6% of flow
Common Stock
SEC:0001437749-22-001184:0 · 19 Jan 2022
Ideal exit: 16 Oct 2022 (T+270) €6,043 1,731 shares @ €3.4913 5.1% of flow
Common Stock
SEC:0001437749-22-001015 · 14 Jan 2022
Ideal exit: 11 Oct 2022 (T+270) €6,043 1,731 shares @ €3.4913 2.4% of flow
Common Stock
SEC:0001437749-22-001015:0 · 14 Jan 2022
Ideal exit: 11 Oct 2022 (T+270) €7,461 2,137 shares @ €3.4913 6.2% of flow
Common Stock
SEC:0001437749-22-000925 · 14 Jan 2022
Ideal exit: 11 Oct 2022 (T+270) €7,461 2,137 shares @ €3.4913 3.0% of flow
Common Stock
SEC:0001437749-22-000925:0 · 14 Jan 2022
Ideal exit: 11 Oct 2022 (T+270) €10,390 3,000 shares @ €3.4632 8.7% of flow
Common Stock
SEC:0001437749-21-028623 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) €10,390 3,000 shares @ €3.4632 4.1% of flow
Common Stock
SEC:0001437749-21-028623:0 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) €19,481 5,000 shares @ €3.8961 16.3% of flow
Common Stock
SEC:0001437749-21-028294 · 10 Dec 2021
Ideal exit: 6 Sept 2022 (T+270) €19,481 5,000 shares @ €3.8961 7.7% of flow
Common Stock
SEC:0001437749-21-028294:0 · 10 Dec 2021
Ideal exit: 6 Sept 2022 (T+270) €3,630 864 shares @ €4.2012 3.0% of flow
Common Stock
SEC:0001437749-21-027904 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €3,630 864 shares @ €4.2012 1.4% of flow
Common Stock
SEC:0001437749-21-027904:0 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €17,356 4,136 shares @ €4.1963 14.5% of flow
Common Stock
SEC:0001437749-21-027685 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €17,356 4,136 shares @ €4.1963 6.9% of flow
Common Stock
SEC:0001437749-21-027685:0 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €22,065 5,000 shares @ €4.4129 18.5% of flow
Common Stock
SEC:0001437749-21-027642 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €22,065 5,000 shares @ €4.4129 8.7% of flow
Common Stock
SEC:0001437749-21-027642:0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) 25 of 29 declarations
Load more (4 remaining) About Ostronic Francis Patrick Francis Patrick Ostronic is an executive at Cyclo Therapeutics, Inc.